Holen Sie sich die Stockscreener-App
349.04
0.96%
-3.37
Vorhandelsmarkt:
348.70
-0.34
-0.10%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$352.41
Offen:
$352.19
24-Stunden-Volumen:
429.41K
Relative Volume:
0.82
Marktkapitalisierung:
$20.82B
Einnahmen:
$2.91B
Nettoeinkommen (Verlust:
$622.64M
KGV:
33.31
EPS:
10.48
Netto-Cashflow:
$620.14M
1W Leistung:
+1.81%
1M Leistung:
-0.06%
6M Leistung:
-5.91%
1J Leistung:
+20.31%
1-Tages-Spanne:
$345.88
$353.59
1-Wochen-Bereich:
$342.79
$358.89
52-Wochen-Spanne:
$279.24
$423.56
Waters Corp Stock (WAT) Company Profile
Firmenname
Waters Corp
Sektor
Branche
Telefon
(508) 478-2000
Adresse
34 MAPLE ST, MILFORD, MA
Vergleichen Sie WAT mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
WAT
Waters Corp
|
349.04 | 20.82B | 2.91B | 622.64M | 620.14M | 10.48 |
|
TMO
Thermo Fisher Scientific Inc
|
405.46 | 156.49B | 42.90B | 6.52B | 6.72B | 17.05 |
|
DHR
Danaher Corp
|
197.54 | 145.01B | 23.82B | 3.77B | 4.90B | 5.15 |
|
IDXX
Idexx Laboratories Inc
|
536.34 | 42.30B | 3.93B | 894.97M | 837.70M | 10.82 |
|
A
Agilent Technologies Inc
|
118.01 | 34.24B | 6.63B | 1.17B | 1.19B | 4.05 |
|
IQV
Iqvia Holdings Inc
|
157.59 | 27.64B | 15.50B | 1.33B | 2.16B | 7.34 |
Waters Corp Stock (WAT) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-03-31 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2025-03-26 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2025-02-13 | Hochstufung | Scotiabank | Sector Perform → Sector Outperform |
| 2025-02-10 | Hochstufung | Barclays | Underweight → Equal Weight |
| 2025-01-10 | Hochstufung | Bernstein | Mkt Perform → Outperform |
| 2024-12-23 | Eingeleitet | Scotiabank | Sector Perform |
| 2024-10-08 | Hochstufung | Jefferies | Hold → Buy |
| 2024-08-28 | Eingeleitet | Wells Fargo | Overweight |
| 2024-08-01 | Hochstufung | Leerink Partners | Market Perform → Outperform |
| 2024-06-03 | Fortgesetzt | Jefferies | Hold |
| 2023-11-13 | Herabstufung | Barclays | Equal Weight → Underweight |
| 2023-09-28 | Eingeleitet | Bernstein | Mkt Perform |
| 2023-07-31 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2023-07-31 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2022-12-14 | Eingeleitet | Deutsche Bank | Hold |
| 2022-08-25 | Eingeleitet | Credit Suisse | Neutral |
| 2022-07-20 | Eingeleitet | UBS | Neutral |
| 2022-05-18 | Eingeleitet | Barclays | Overweight |
| 2022-05-17 | Hochstufung | BofA Securities | Underperform → Neutral |
| 2022-04-25 | Hochstufung | Wells Fargo | Underweight → Equal Weight |
| 2021-10-15 | Fortgesetzt | Cowen | Market Perform |
| 2021-07-06 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2021-01-07 | Herabstufung | Wells Fargo | Equal Weight → Underweight |
| 2020-12-17 | Hochstufung | Cleveland Research | Underperform → Buy |
| 2020-12-16 | Hochstufung | Citigroup | Sell → Neutral |
| 2020-12-02 | Eingeleitet | Goldman | Neutral |
| 2020-11-10 | Eingeleitet | KeyBanc Capital Markets | Sector Weight |
| 2020-07-28 | Hochstufung | JP Morgan | Underweight → Neutral |
| 2020-07-16 | Hochstufung | Wells Fargo | Underweight → Equal Weight |
| 2020-01-08 | Herabstufung | Needham | Hold → Underperform |
| 2020-01-08 | Eingeleitet | Wells Fargo | Underweight |
| 2020-01-07 | Eingeleitet | Citigroup | Sell |
| 2019-11-15 | Eingeleitet | Stifel | Hold |
| 2019-10-09 | Herabstufung | Barclays | Equal Weight → Underweight |
| 2019-07-16 | Herabstufung | BofA/Merrill | Neutral → Underperform |
| 2019-06-12 | Herabstufung | Cleveland Research | Neutral → Underperform |
| 2019-05-30 | Eingeleitet | Wolfe Research | Underperform |
| 2019-01-24 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2019-01-03 | Hochstufung | BofA/Merrill | Underperform → Neutral |
| 2019-01-03 | Eingeleitet | Needham | Hold |
| 2018-12-12 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2018-11-30 | Herabstufung | Goldman | Neutral → Sell |
| 2018-10-11 | Hochstufung | Cleveland Research | Sell → Neutral |
Alle ansehen
Waters Corp Aktie (WAT) Neueste Nachrichten
Waters launches enhanced HPLC system with user authentication By Investing.com - Investing.com South Africa
Waters launches enhanced HPLC system with user authentication - Investing.com
Waters Enhances Alliance iS HPLC System Software, Setting a New Standard for End-to-End Traceability and Data Integrity - PR Newswire
How Waters Co. (NYSE:WAT) Aligns With Evolving Scientific Trends in the S&P 500 Landscape? - Kalkine Media
Waters Corporation’s SWOT analysis: stock poised for growth amid biotech boom - Investing.com
Here's Why Waters (WAT) is a Strong Growth Stock - Yahoo Finance
Waters (NYSE:WAT) Rating Lowered to Hold at Wall Street Zen - Defense World
Deutsche Bank Adjusts Price Target on Waters to $375 From $395 - marketscreener.com
Transcript : Waters Corporation Presents at Jefferies Global Healthcare Conference 2025, Jun-04-2025 08 - marketscreener.com
Waters sets a new benchmark for robustness and sensitivity for high-throughput labs with the Xevo TQ Absolute XR Mass Spectrometer - SelectScience
Waters Sets a New Benchmark for Robustness and Sensitivity for High-Throughput Labs with the Xevo TQ Absolute XR Mass Spectrometer - Yahoo Finance
KeyBanc reiterates overweight rating on Waters Corp stock - Investing.com
KeyBanc reiterates overweight rating on Waters Corp stock By Investing.com - Investing.com UK
New Waters Mass Spectrometer Delivers Revolutionary 6X Performance Jump While Cutting Lab Costs in Half - Stock Titan
Waters Corporation (WAT) Announces Amendment to Credit Agreement - GuruFocus
Waters (NYSE:WAT) Downgraded by Wall Street Zen to “Hold” - Defense World
Why Waters (WAT) is a Top Growth Stock for the Long-Term - Yahoo Finance
Waters Introduces BioResolve Protein A Affinity Columns to Accelerate Antibody Titer Measurement, Enhancing Process Agility and Batch Quality - marketscreener.com
Waters New Protein A Columns Cut Drug Development Time by 2 Days, Boost Sensitivity 7X - Stock Titan
Waters Corporation’s SWOT analysis: stock outlook amid biotech boom - Investing.com
Waters Corporation’s SWOT analysis: stock outlook amid biotech boom By Investing.com - Investing.com South Africa
Waters Corp (WAT) Stock Price Up 3.88% on May 27 - GuruFocus
Waters acquires Halo Labs, expanding biological analysis portfolio - SelectScience
Do Wall Street Analysts Like Waters Stock? - MSN
Waters Corporation (WAT) Announces Results of Annual Stockholders Meeting - GuruFocus
Waters Corp. acquires specialized imaging firm Halo Labs - Worcester Business Journal
Petri Dish: Thermo Fisher’s new partner; Waters buys California company - The Business Journals
Waters Corporation acquired Optofluidics, Inc. - marketscreener.com
Waters Acquires Halo Labs, Expands Biologic Analysis Portfolio - Contract Pharma
Waters Acquires Halo Labs - marketscreener.com
Waters (WAT) Enhances Capabilities with Acquisition of Halo Labs - GuruFocus
Waters (WAT) Enhances Capabilities with Acquisition of Halo Labs | WAT Stock News - GuruFocus
Waters Acquires Halo Labs, Expanding Biological Analysis Portfolio - PR Newswire
Waters Co. (NYSE:WAT) Stock Position Raised by Cetera Investment Advisers - Defense World
Waters (WAT) Sees Price Target Increase Amid Market Caution | WAT Stock News - GuruFocus
Ameriprise Financial Inc. Trims Stake in Waters Co. (NYSE:WAT) - Defense World
HSBC lifts Carnival Corp. rating as it is now ‘in calmer waters’ - Investing.com Australia
Waters Co. (NYSE:WAT) Receives Consensus Recommendation of “Moderate Buy” from Brokerages - Defense World
Waters Corp's India business boosted by rush for weight-loss drugs - MSN
Waters Corp. stock outperforms competitors on strong trading day - MarketWatch
Waters CEO Brings Analytical Instruments Innovation to Jefferies Healthcare Conference 2025 - Stock Titan
Waters Sees Surge in India Demand as Drugmakers Race to Develop Weight-Loss Drug Generics - marketscreener.com
Waters Integrates Multi-Angle Light Scattering Detectors with Empower Software for Improved Biologics Quality Control and Simplified Regulatory CompliancePR Newswire APAC - PR Newswire Asia
Waters Corporation, Avantor, Azenta, Bio-Techne, and Elanco Stocks Trade Up, What You Need To Know - Yahoo Finance
What Makes Waters Corporation (WAT) a Lucrative Investment? - Yahoo Finance
3 Profitable Stocks in the Doghouse - FinancialContent
Waters (NYSE:WAT) Stock Unloaded Rep. Robert Bresnahan, Jr. - Defense World
Leerink Partnrs Has Negative Forecast for Waters Q3 Earnings - Defense World
Q2 Earnings Estimate for Waters Issued By Leerink Partnrs - Defense World
Waters (WAT) Stock Price Target Raised by Baird Analyst | WAT St - GuruFocus
Analyst Expectations For Waters's Future - Benzinga
Finanzdaten der Waters Corp-Aktie (WAT)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.74%
0.83%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):